Literature DB >> 1699188

Congenital nephrosis as a cause of elevated alpha-fetoprotein.

S G Albright1, A A Warner, J W Seeds, B K Burton.   

Abstract

Two cases of congenital nephrosis were detected through routine maternal serum alpha-fetoprotein (MSAFP) screening of 95,135 patients. No other cases of congenital nephrosis from this group were reported, resulting in an incidence of approximately one in 47,500 in this low-risk population. In both of these cases, similar to other reported cases of congenital nephrosis having MSAFP screening, the protein concentrations were greater than or equal to 10 multiples of the median (MOM). Therefore, in the case of an MSAFP over 10 MOM and a normal ultrasound examination, congenital nephrosis should be included in counseling regarding the possibility of undetected malformations. Furthermore, in the case of a pregnancy with elevated amniotic fluid AFP with negative acetylcholinesterase and normal ultrasound, the possibility of congenital nephrosis should be mentioned, regardless of family history or ancestry. When a pregnancy is terminated because of these biochemical findings, special and immediate attention to the fetal kidneys using electron microscopy is necessary to evaluate properly the possibility of congenital nephrosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699188

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan.

Authors:  Yuko Hamasaki; Masaki Muramatsu; Riku Hamada; Kenji Ishikura; Hiroshi Hataya; Hiroyuki Satou; Masataka Honda; Koichi Nakanishi; Seiichiro Shishido
Journal:  Clin Exp Nephrol       Date:  2017-11-28       Impact factor: 2.801

2.  Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations.

Authors:  U Lenkkeri; M Männikkö; P McCready; J Lamerdin; O Gribouval; P M Niaudet; K Antignac C; C E Kashtan; C Homberg; A Olsen; M Kestilä; K Tryggvason
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.